ArticleFrontiers in cardiovascular medicine2026
Impact of anatomic complexity of congenital heart disease on growth retardation: a large retrospective cohort study.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Growth retardation (GR) is a significant comorbidity in children with congenital heart disease (CHD), particularly those with complex CHD. This study aimed to characterize the growth patterns of pediatric CHD patients and to identify the factors associated with GR. Methods: This retrospective cohort study included CHD patients aged ≤18 years from the First Hospital of Hebei Medical University between January 2014 and March 2024. Patients were classified into complex or non-complex CHD groups based on echocardiographic diagnoses. Clinical, laboratory, and echocardiographic parameters were compared. Independent factors associated with GR were identified and used to construct a nomogram for identifying the likelihood of existing GR. Results: A total of 2,784 patients were included (260 with complex CHD and 2,524 with non-complex CHD). Patients with complex CHD had higher prevalence of growth impairment than those with non-complex CHD. GR (35.4% vs. 16.0%), short stature (30.0% vs. 15.1%), and underweight (27.3% vs. 13.4%) were more common in complex CHD than in non-complex CHD patients. Complex CHD, younger age, presence of pulmonary arterial hypertension, and hypoalbuminemia were identified as independent factors associated with GR. A nomogram incorporating these factors demonstrated performance in screening for prevalent GR, with an area under the receiver operating characteristic curve of 0.75 in the temporal validation cohort. Conclusions: The prevalence of GR is high in children with CHD, especially among those with complex CHD. Our findings highlight the necessity of integrating routine growth surveillance into the standard of care for this population. The nomogram facilitates the identification of children with a high probability of GR, enabling timely intervention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.